跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 78,280 条关于
“high-risk myelodysplastic syndromes”
全部
78,280
临床试验
57,266
药物
536
机构
249
资讯
20,229
3小时前
LYT-200 Wins FDA Fast Track for High-Risk MDS
去年
ESA Treatment Shows Survival Benefit in Lower-Risk Myelodysplastic Syndromes
2年前
Taiho Oncology Announces Publication of Final Results from ASCERTAIN Clinical Trial
9个月前
VERONA Trial Shows Mixed Results for Venetoclax-Azacitidine Combination in High-Risk MDS
2年前
Tapotoclax Shows Limited Efficacy in Myelodysplastic Syndromes After HMA Failure
去年
Canakinumab Shows Promise in Treating Relapsed/Refractory Lower-Risk Myelodysplastic Syndromes
去年
Study Reveals Significant Treatment Disparities in High-Risk Myelodysplastic Syndrome Patients
去年
Remedy Plan Therapeutics Secures $18 Million to Advance Novel NAMPT Inhibitor for AML and MDS Treatment
去年
Schrödinger Discontinues Blood Cancer Drug SGR-2921 After Two Patient Deaths in Phase I Trial
去年
Faron Pharmaceuticals Reports 43% Complete Remission Rate in High-Risk Myelodysplastic Syndrome Trial
第 1 页,共 2023 页
上一页
下一页